SPG4

SPG4 refers to the gene that encodes for the protein spastin, which is involved in the regulation of microtubule dynamics within cells. It is located on chromosome 2q24.3 and is a key gene associated with hereditary spastic paraplegia (HSP), a group of inherited neurological disorders characterized by progressive weakness and spasticity of the lower limbs.

Spastin, the protein produced by the SPG4 gene, functions primarily as an ATPase that severs and disassembles microtubules, thereby playing a crucial role in neuronal maintenance and axonal transport. Proper functioning of spastin is essential for the health of long motor neurons, which are particularly susceptible to disruptions in microtubule regulation.

Mutations in the SPG4 gene are the most common cause of autosomal dominant hereditary spastic paraplegia, accounting for approximately 40-50% of cases. These mutations often lead to haploinsufficiency or altered spastin proteins that impair microtubule severing activity, resulting in axonal degeneration and the clinical features of HSP.

Clinically, individuals with SPG4 mutations typically exhibit progressive spastic weakness, hyperreflexia, and gait disturbances, primarily affecting the lower extremities. The onset can vary from childhood to adulthood, and the severity depends on the mutation's nature and the extent of neuronal impairment.

Research into SPG4 is ongoing, aiming to understand its role in neuronal biology and explore potential therapeutic strategies for hereditary spastic paraplegia. Genetic testing for SPG4 mutations can aid in diagnosis and genetic counseling for affected families.